What is Metropolis Healthcare Ltd's market cap?

Metropolis Healthcare Ltd (METROPOLIS) has a market capitalization of ₹10,524 Cr.

What sector is METROPOLIS in?

Metropolis Healthcare Ltd operates in the Healthcare — Hospitals & Diagnostics sector.

What is METROPOLIS's return on equity?

Metropolis Healthcare Ltd has a return on equity (ROE) of 11.8%.

Loading company...

Analyzing...

Metropolis Healthcare Ltd (METROPOLIS) — Analysis, Financials, Intelligence | The Stock Filter

The Organism · Company Intelligence

Metropolis Healthcare Ltd

METROPOLIS|BSE: 542650

Healthcare — Hospitals & DiagnosticsHealthcare & Life Scienceswww.metropolisindia.com

—

—|MCap ₹10,524 Cr

Metropolis Healthcare Ltd. owns and operates medical laboratories. The company is headquartered in Gurgaon, Haryana and currently employs 4,289 full-time employees. The company went IPO on 2019-04-15.

Secular Currents

Theme Connections

Healthcare Access Insurance Penetration

Intelligence Profile

TSF Score

63/100

The Vitals · Company Health

Health Indicators

Shenanigan Score

17Clean

Trust Score

X-Ray

Concerns

🟠Profit decliningBusiness

Watch

Nothing flagged for monitoring

Strengths

🟢Good profitability (Net margin: 10.6%)Business
🟢Low leverage (D/E: 0.01x)Business
🟢Consistent dividend payerOpportunity

The Numbers · Key Metrics

ROE

11.8%

Revenue Growth 3yr

2.6%

Debt/Equity

0.01x

₹10,484 Cr

The Narrator · StoryTel Intelligence

FY2025Healthcare — Hospitals & DiagnosticsProduct Sales ModelModel:Revenue = Number of Patients × Average Revenue per Patient (ARPOB for hospitals; Revenue per Test for diagnostics)

Key Insight

“Services business in Healthcare — Hospitals & Diagnostics.”

The Revenue Story

₹1,331 Cr service revenue.

Total Income₹1,346 Cr

Revenue₹1,331 Cr(98.9% of Total Income)

Other Income₹15 Cr(1.1% of Total Income)

The Cost Story

Employee costs at 23.6% of revenue — primary cost driver.

Other Expenses₹446 Cr(30.6%)

Employee₹314 Cr(21.5%)

EBITDA₹303 Cr(20.8%)

Subcontracting₹269 Cr(18.4%)

Depreciation₹109 Cr(7.5%)

Finance Costs₹19 Cr(1.3%)

0.2%EBITDA Margin

Other Expenses

30.6%

Employee

21.5%

EBITDA

20.8%

Subcontracting

18.4%

Depreciation

7.5%

Finance Costs

1.3%

Key Metrics

ROE

11.8%

vs median 7.9%

ROCE

14.6%

vs median 11.3%

Net Margin

10.6%

vs median 9.3%

EBITDA Margin

23.3%

vs median 21.9%

Debt To Equity

0.01x

vs median 0.16x

Rev Growth 3yr

2.6%

vs median 12.4%

EPS Growth 3yr

-12.5%

vs median 11.8%

Employee Cost Ratio

23.60x

Forward View · Management Guidance

GUIDANCEQ3FY26— 2High Impact

“we remain confident of delivering on our guidance of 12 to 13% organic growth rate and expanded margins for f y twenty six”

FINANCIALQ3FY26— SurendranHigh Impact

“group revenues growing 26% year on year and nine month revenues increasing by 24%”

FINANCIALQ3FY26High Impact

“EBITDA margin stood at 25%, an”

The Context · Where does it sit?

Sector Context

The Canopy · Sector KPIs

Sector KPIs

Healthcare — Hospitals & Diagnostics

KPI	Company	Sector Median
ROE	11.8%▲	7.9%
ROCE	14.6%▲	11.3%
Net Margin	10.6%▲	9.3%
EBITDA Margin	23.3%▲	21.9%
Debt To Equity	0.01x▼	0.16x
Rev Growth 3yr	2.6%▼	12.4%
EPS Growth 3yr	-12.5%▼	11.8%
Employee Cost Ratio	23.60x	-

The Market · What is the market saying?

Market Signals

The Antenna · Media Intelligence

Media Signal

Moderate Impact

7d+0.94→30d+0.94

Based on 1 article (0 in last 7 days)

The Numbers · Show me the data

Financials

No valuation data

Historical valuation data not available.

Financials

Revenue₹1,566 Cr

PBT₹225 Cr

EPS₹8.12

(₹ Cr)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	₹1,566 Cr +17.7%	₹1,331 Cr +10.2%	₹1,208 Cr +5.2%	₹1,148 Cr -6.5%	₹1,228 Cr +23.1%	₹998 Cr +16.5%	₹856 Cr +12.5%	₹761 Cr
Other Income	₹24 Cr +61.4%	₹15 Cr +65.8%	₹9 Cr -40.1%	₹15 Cr -13.6%	₹18 Cr +46.3%	₹12 Cr +40.6%	₹9 Cr +4.3%	₹8 Cr
Total Income	₹1,591 Cr +18.2%	₹1,346 Cr +10.6%	₹1,217 Cr +4.6%	₹1,163 Cr -6.6%	₹1,246 Cr +23.4%	₹1,010 Cr +16.8%	₹865 Cr +12.4%	₹769 Cr
COGS	₹318 Cr +18.2%	₹269 Cr +10.8%	₹243 Cr -4.2%	₹253 Cr -8.2%	₹276 Cr +9.5%	₹252 Cr +23.5%	₹204 Cr +17.7%	₹174 Cr
	₹1,356 Cr +17.4%	₹1,155 Cr +10.9%	₹1,042 Cr +6.8%	₹976 Cr +0.8%	₹969 Cr +26.5%	₹766 Cr +14.1%	₹671 Cr +15.4%	₹581 Cr
Profit Before Tax	₹225 Cr +18.1%	₹191 Cr +9.3%	₹175 Cr -6.8%	₹188 Cr -36.1%	₹293 Cr +20.1%	₹244 Cr +44.4%	₹169 Cr -9.3%	₹187 Cr
Exceptional Items	(₹9 Cr)	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr -100.0%	₹16 Cr	₹0.00 Cr +100.0%	(₹25 Cr)	(₹1 Cr)
	₹56 Cr +23.5%	₹45 Cr -1.9%	₹46 Cr +4.8%	₹44 Cr -43.9%	₹79 Cr +29.0%	₹61 Cr +48.1%	₹41 Cr -34.6%	₹63 Cr
Net Profit	₹169 Cr +16.5%	₹146 Cr +13.3%	₹128 Cr -10.4%	₹143 Cr -33.2%	₹215 Cr +17.1%	₹183 Cr +43.7%	₹128 Cr +3.2%	₹124 Cr
Profit (Owners)	₹168 Cr +16.1%	₹145 Cr +13.4%	₹128 Cr -10.5%	₹143 Cr -33.3%	₹214 Cr +17.0%	₹183 Cr +43.8%	₹127 Cr +6.0%	₹120 Cr
Minority Interest	₹1 Cr +119.5%	₹0.55 Cr -14.7%	₹0.64 Cr +25.0%	₹0.51 Cr +1.5%	₹0.50 Cr +98.7%	₹0.25 Cr +11.9%	₹0.23 Cr -93.5%	₹3 Cr
Other Comprehensive Income	₹3 Cr ↑ Recovery	(₹0.31 Cr) +62.0%	(₹0.82 Cr) -136.3%	(₹0.35 Cr) +85.0%	(₹2 Cr) -114.5%	(₹1 Cr) +64.0%	(₹3 Cr) ↓ Decline	₹1 Cr
EPS	₹8.12	₹7.00	₹6.24	₹6.98	₹10.46	₹8.95	₹6.29	₹5.99
Diluted Shares	₹21 Cr	₹21 Cr	₹20 Cr	₹20 Cr	₹20 Cr	₹20 Cr	₹20 Cr	₹20 Cr